Repros Therapeutics Inc (RPRX)

[Bio_pete]

REPROS VALUATION QUESTION AGAIN

I think your on the right track. Find drugs with comparable stages of development, estimated revenues, and competition to determine the potential buy-out target.

ILY101 has estimated revenues of $500 million to $1 billion by 2015. Competition by Renagel, from Genzyme which is also working on an improved version.

Proellex has estimated revenues of $1 billion + by 2015. No competition.

The buy-out from Amgen was $420 million. Looks like you should take that figure and increase it substantially for Proellex. I'm estimating $600 - $800 million.

Androxal is further along in development, revenues at least $500 million, competition from transdermal. Buy-out in the $300 - $400 million range.